Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
在巴西患有自身免疫性风湿病的SARS-CoV-2血清阳性和血清阴性患者中,两剂CoronaVac SARS-CoV-2疫苗的免疫原性和安全性:一项4期前瞻性研究的亚组分析
期刊:Lancet Rheumatology
影响因子:16.4
doi:10.1016/S2665-9913(21)00327-1
Aikawa, Nadia E; Kupa, Leonard V K; Pasoto, Sandra G; Medeiros-Ribeiro, Ana C; Yuki, Emily F N; Saad, Carla G S; Pedrosa, Tatiana; Fuller, Ricardo; Shinjo, Samuel K; Sampaio-Barros, Percival D; Andrade, Danieli C O; Pereira, Rosa M R; Seguro, Luciana P C; Valim, Juliana M L; Waridel, Filipe; Sartori, Ana Marli C; Duarte, Alberto J S; Antonangelo, Leila; Sabino, Ester C; Menezes, Paulo Rossi; Kallas, Esper G; Silva, Clovis A; Bonfa, Eloisa